Cardiac surgery in a patient with implanted vagal nerve stimulator.
Cardiac surgery in a patient with implanted vagal nerve stimulator.
复制标题
DOI：
10.4103/aca.aca_108_17
复制
发表时间：
2018-01
影响因子：
0.9
通讯作者：
Mehta Y
中科院分区：
文献类型：
--
作者：
Jain A;Arora D;Mehta Y
全球癫痫的患病率约为人口的0.5%-2%。抗癫痫药物是大多数情况下的一线治疗，但约25%-30%的癫痫患者对单一或联合治疗无效。颞叶癫痫的手术选择是颞叶切除术，手术后有神经功能缺损的固有风险。对联合治疗无效或不想进行手术颞叶切除术的患者是电刺激治疗的候选人。难治性病例需要植入器械，如迷走神经刺激器（VNS）。我们正在报告一名植入VNS并准备进行心包切除术的患者的围手术期管理。麻醉医师熟悉迷走神经刺激的发生机制，对围手术期的正确护理具有重要意义。
The prevalence of epilepsy worldwide is around 0.5%–2% of the population. Antiepileptic medications are the first line of treatment in most of the cases but approximately 25%–30% epilepsy patients are refractory to the single or combination therapy. The surgical option for temporal lobe epilepsy is temporal lobectomy, which has its inherent risk of neurological deficits after the surgery. Patients who are either refractory to combination therapy or do not want surgical temporal lobectomy are the candidates for electrical stimulation therapy. Refractory cases require implantable device such as vagal nerve stimulator (VNS). We are reporting perioperative management of a patient, with an implanted VNS, posted for pericardiectomy. It is important for the anesthesiologist to be familiar with the mechanism of VNS for proper perioperative care.